NL185146C - Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd. - Google Patents
Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd.Info
- Publication number
- NL185146C NL185146C NLAANVRAGE8020199,A NL8020199A NL185146C NL 185146 C NL185146 C NL 185146C NL 8020199 A NL8020199 A NL 8020199A NL 185146 C NL185146 C NL 185146C
- Authority
- NL
- Netherlands
- Prior art keywords
- aggregation
- alkoxy group
- inhibitory effect
- pharmaceutical preparation
- derivative substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2565880A JPS56122356A (en) | 1980-02-29 | 1980-02-29 | Carbostyril derivative |
| JP2565880 | 1980-02-29 | ||
| PCT/JP1980/000122 WO1981002421A1 (fr) | 1980-02-29 | 1980-06-04 | Derive de carbostyrile |
| JP8000122 | 1980-06-04 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8020199A NL8020199A (nl) | 1981-12-01 |
| NL185146B NL185146B (nl) | 1989-09-01 |
| NL185146C true NL185146C (nl) | 1990-02-01 |
Family
ID=12171902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE8020199,A NL185146C (nl) | 1980-02-29 | 1980-06-04 | Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4435404A (cs) |
| JP (1) | JPS56122356A (cs) |
| KR (2) | KR860002099B1 (cs) |
| AT (1) | AT381493B (cs) |
| AU (1) | AU532319B2 (cs) |
| BE (1) | BE883713A (cs) |
| CA (1) | CA1159068A (cs) |
| CH (1) | CH647765A5 (cs) |
| DE (1) | DE3049959T1 (cs) |
| DK (1) | DK151956C (cs) |
| ES (1) | ES492230A0 (cs) |
| FI (1) | FI76321C (cs) |
| FR (1) | FR2477149A1 (cs) |
| GB (1) | GB2070588B (cs) |
| IT (1) | IT1129812B (cs) |
| MX (1) | MX6752E (cs) |
| NL (1) | NL185146C (cs) |
| NO (1) | NO160512C (cs) |
| PH (1) | PH18532A (cs) |
| PT (1) | PT71359B (cs) |
| SE (1) | SE461147B (cs) |
| SU (2) | SU1169535A3 (cs) |
| WO (1) | WO1981002421A1 (cs) |
| ZA (1) | ZA803322B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| DE3434271A1 (de) * | 1984-09-19 | 1986-03-20 | Beiersdorf Ag, 2000 Hamburg | Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| US5227381A (en) * | 1988-05-02 | 1993-07-13 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative |
| JP2753622B2 (ja) | 1988-05-02 | 1998-05-20 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| CA2093633A1 (en) * | 1991-08-23 | 1993-02-24 | Seiji Sato | Carbostyril derivative and platelets aggregation inhibitory agent |
| JP2686887B2 (ja) * | 1992-08-11 | 1997-12-08 | キッセイ薬品工業株式会社 | ピペリジノ−３，４−ジヒドロカルボスチリル誘導体 |
| US7208497B2 (en) | 2001-07-02 | 2007-04-24 | Novo Nordisk A/S | Substituted piperazines and diazepanes |
| DE10316081A1 (de) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| TWI481601B (zh) * | 2009-08-21 | 2015-04-21 | Otsuka Pharma Co Ltd | 含氮化合物及藥學組成物 |
| JP5649577B2 (ja) | 2009-08-21 | 2015-01-07 | 大塚製薬株式会社 | ベンゾ［ｂ］［１，４］ジアゼピン−２，４−ジオン化合物の製造方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1021522A (en) * | 1963-05-10 | 1966-03-02 | Ici Ltd | 2-quinolone derivatives |
| DE1527937A1 (de) * | 1966-12-10 | 1969-11-13 | Blanc & Co | Verfahren zur Herstellung eines sich konisch verjuengenden,einen nach aussen abgewinkelten flachen Rand aufweisenden Hohlteils sowie Einrichtung zur Durchfuehrung des Verfahrens |
| JPS48103590A (cs) * | 1972-04-13 | 1973-12-25 | ||
| JPS5082218A (cs) * | 1973-11-10 | 1975-07-03 | ||
| JPS5310988B2 (cs) * | 1974-04-25 | 1978-04-18 | ||
| JPS5318030B2 (cs) * | 1974-05-20 | 1978-06-13 | ||
| US4313947A (en) | 1974-06-24 | 1982-02-02 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use |
| FI59246C (fi) * | 1974-06-24 | 1981-07-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin |
| US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
| JPS5273879A (en) * | 1975-12-18 | 1977-06-21 | Otsuka Pharmaceut Co Ltd | Synthesis of ester derivatives |
| JPS545981A (en) * | 1977-06-10 | 1979-01-17 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
| IE46852B1 (en) | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
-
1980
- 1980-02-29 JP JP2565880A patent/JPS56122356A/ja active Granted
- 1980-06-04 AU AU59859/80A patent/AU532319B2/en not_active Ceased
- 1980-06-04 AT AT0909480A patent/AT381493B/de not_active IP Right Cessation
- 1980-06-04 US US06/261,177 patent/US4435404A/en not_active Expired - Fee Related
- 1980-06-04 ZA ZA00803322A patent/ZA803322B/xx unknown
- 1980-06-04 CH CH6674/81A patent/CH647765A5/de not_active IP Right Cessation
- 1980-06-04 DE DE803049959T patent/DE3049959T1/de active Granted
- 1980-06-04 PH PH24106A patent/PH18532A/en unknown
- 1980-06-04 NL NLAANVRAGE8020199,A patent/NL185146C/xx not_active IP Right Cessation
- 1980-06-04 WO PCT/JP1980/000122 patent/WO1981002421A1/ja not_active Ceased
- 1980-06-05 KR KR1019800002229A patent/KR860002099B1/ko not_active Expired
- 1980-06-06 ES ES492230A patent/ES492230A0/es active Granted
- 1980-06-06 MX MX808865U patent/MX6752E/es unknown
- 1980-06-06 GB GB8018609A patent/GB2070588B/en not_active Expired
- 1980-06-06 IT IT67888/80A patent/IT1129812B/it active
- 1980-06-06 CA CA000353541A patent/CA1159068A/en not_active Expired
- 1980-06-06 PT PT71359A patent/PT71359B/pt unknown
- 1980-06-09 FR FR8012744A patent/FR2477149A1/fr active Granted
- 1980-06-09 FI FI801843A patent/FI76321C/fi not_active IP Right Cessation
- 1980-06-09 BE BE0/200953A patent/BE883713A/fr not_active IP Right Cessation
-
1981
- 1981-04-29 SE SE8102690A patent/SE461147B/sv not_active IP Right Cessation
- 1981-05-11 SU SU813280901A patent/SU1169535A3/ru active
- 1981-06-09 DK DK250381A patent/DK151956C/da not_active IP Right Cessation
- 1981-10-15 NO NO81813477A patent/NO160512C/no unknown
-
1982
- 1982-06-18 SU SU823456112A patent/SU1395140A3/ru active
-
1984
- 1984-05-29 KR KR1019840002957A patent/KR860002100B1/ko not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL183888C (nl) | Carbostyrilderivaat met een remmende werking op de aggregatie van bloedplaatjes, werkwijze ter bereiding van deze derivaten, farmaceutisch preparaat dat een dergelijk derivaat bevat en werkwijze ter bereiding van dergelijke farmaceutische preparaten. | |
| NL183358C (nl) | Farmaceutisch preparaat, en daarin te gebruiken penicillaanzuur-derivaat met beta-lactamase-remmende werking. | |
| NL183189C (nl) | Farmaceutisch preparaat dat een met een (piperazine-1-yl)alkoxygroep gesubstitueerd carbostyrilderivaat bevat, alsmede een dergelijk carbostyrilderivaat. | |
| FI812326A7 (fi) | Uusia trisubstituoituja imidatsolijohdannaisia, menetelmiä niiden valmistamiseksi, näitä sisälsisältäviä farmaseuttisia valmisteita ja niiden käyttö. | |
| NL190580C (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
| NL178074C (nl) | Geneeskrachtige preparaten met een remmende werking op de aggregatie van bloedplaatjes en op de fosfodiesterase, alsmede in deze preparaten te gebruiken carbostyrilderivaten. | |
| NL930046I2 (nl) | Gesubstitueerde iminodizuren, hun bereiding en henbevattende farmaceutische mengsels. | |
| NL190554B (nl) | Cefalosporinederivaat, en farmaceutisch of veterinair preparaat met antibacteriele werking, dat dit cefalosporinederivaat bevat. | |
| FI812810A7 (fi) | Ammoniometyyliyhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmaseuttisia valvalmisteita ja viimemainittujen käyttö. | |
| NL185146C (nl) | Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd. | |
| FI813422A7 (fi) | 1-Karboksi-atsa-alkanoyyli- indoliini- karboksyylihappoja, menetelmiä niiden valmistamiseksi, näitä yhdisteitsisältäviä farmaseuttisia valmisteita ja niiden terapeuttinen käyttö. | |
| NL187912C (nl) | Farmaceutisch preparaat dat een carbostyrilderivaat bevat, alsmede carbostyrilderivaat, gesubstitueerd door een (1-piperidyl)alkoxygroep. | |
| NL169591B (nl) | Werkwijze voor het bereiden van 2-4-(2-furoyl)-piperazine-1-yl-4-amino-6,7-dimethoxychinazoline.hydrochloride met bloeddrukverlagende werking en van een geneesmiddel met bloeddrukverlagende werking dat dit zout bevat. | |
| FI801020A7 (fi) | 5-substituoituja pyranoni-yhdisteitä ja niiden käyttö lääkevalmisteina. | |
| ATA645976A (de) | Fungicide mittel | |
| FI791639A7 (fi) | Uusia imidatsolijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia valmisteita. | |
| DD131712A5 (de) | Insektizide mittel | |
| FI832884A7 (fi) | Desoksiuridiini-johdannaiset, niiden valmistusmenetelmät ja käyttö farmaseuttisina aineina. | |
| TR18891A (tr) | 1-(2-halojeno-2-fenil-etil)-triazoller,bunlarin hazirlanisina ait usul ve bunlarin fungisidler olarak kullanilmalar | |
| FI810835A7 (fi) | Uusia tioformamidijohdannaisia, niiden valmistaminen ja niitä sisältävät lääkkeet. | |
| DK148875C (da) | Blodfilterelement, isaer til brug ved blodtransfusioner | |
| FI801019A7 (fi) | 6-substituoituja pyranoni-yhdisteitä ja niiden käyttö lääkevalmisteina. | |
| NL7900966A (nl) | Nieuwe 3-fenyltetrahydropyridine-derivaten en de zouten daarvan, werkwijze ter bereiding daarvan, de toepassing daarvan als geneesmiddelen en farmaceutische prepara- ten, die deze derivaten bevatten. | |
| FI814175A7 (fi) | Tiatsoliinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö sekä näihin yhdisteisiin perustuperustuvia farmaseuttisia valmisteita. | |
| FI830898A7 (fi) | Sulfonyyliureoita, menetelmiä niiden valmistamiseksi, näihin yhdisteisiin pohjautuvia farmaseuttisia valmisvalmisteita sekä niiden käyttö. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| V1 | Lapsed because of non-payment of the annual fee |